We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFA
676
MFA Financial
MFA
$933M
– –
-14,794
Closed -$152K
MHK icon
677
Mohawk Industries
MHK
$9.22B
– –
-2,627
Closed -$300K
MRSH
678
Marsh
MRSH
$91.5B
– –
-1,093
Closed -$267K
MQ icon
679
Marqeta
MQ
$1.66B
– –
-7,428
Closed -$122K
MRK icon
680
Merck
MRK
$318B
– –
-16,029
Closed -$1.44M
MRVI icon
681
Maravai LifeSciences
MRVI
$919M
– –
-13,168
Closed -$29.1K
MRVL icon
682
Marvell Technology
MRVL
$196B
– –
-16,890
Closed -$1.04M
MSTR icon
683
Strategy Inc
MSTR
$38.4B
– –
-1,416
Closed -$408K
MTSI icon
684
MACOM Technology Solutions
MTSI
$23.7B
– –
-5,963
Closed -$599K
NCLH icon
685
Norwegian Cruise Line
NCLH
$8.84B
– –
-10,196
Closed -$193K
NCMI icon
686
National CineMedia
NCMI
$378M
– –
-26,618
Closed -$155K
NET icon
687
Cloudflare
NET
$107B
– –
-2,579
Closed -$291K
NEU icon
688
NewMarket
NEU
$8.18B
– –
-450
Closed -$255K
NFE icon
689
New Fortress Energy
NFE
$101M
– –
-10,230
Closed -$85K
NI icon
690
NiSource
NI
$20.4B
– –
-23,840
Closed -$956K
NOC icon
691
Northrop Grumman
NOC
$81.2B
– –
-899
Closed -$460K
NRC icon
692
NRC Health Common Stock
NRC
$450M
– –
-10,379
Closed -$133K
NTAP icon
693
NetApp
NTAP
$37.2B
– –
-2,708
Closed -$238K
NWSA icon
694
News Corp Class A
NWSA
$15.4B
– –
-30,065
Closed -$818K
NXST icon
695
Nexstar Media Group
NXST
$5.97B
– –
-1,572
Closed -$282K
OABI icon
696
OmniAb
OABI
$447M
– –
-20,388
Closed -$48.9K
OC icon
697
Owens Corning
OC
$12.4B
– –
-2,068
Closed -$295K
OFIX icon
698
Orthofix Medical
OFIX
$419M
– –
-17,511
Closed -$286K
OI icon
699
O-I Glass
OI
$1.08B
– –
-10,148
Closed -$116K
ON icon
700
ON Semiconductor
ON
$31.6B
– –
-17,072
Closed -$695K
26 27
28
29 30

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.